ferulic acid
Small moleculeexperimental
Ferulic acid is a hydroxycinnamic acid derivative and a phenolic compound. It is an organic compound with the formula (CH3O)HOC6H3CH=CHCO2H. The name is derived from the genus Ferula, referring to the giant fennel (Ferula communis). Classified as a phenolic phytochemical, ferulic acid is an amber colored solid. Esters of ferulic acid are found in plant cell walls, covalently bonded to hemicellulose such as arabinoxylans. Salts and esters derived from ferulic acid are called ferulates. — Wikipedia
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2008 (NCT00777543)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFerulic acid ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03451760 | Phase 2 | Sep 30, 2018 | Department of Veteran Affairs, Fujitsu, Oregon Health and Science University |
| NCT00777543 | N/A | Nov 30, 2008 | Maastricht University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2018 |
| Fujitsu | For profit | 1 | 1 | 1 | 2018 |
| Maastricht University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Oregon Health and Science University | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1